Mouse anti Human CD2 FITC - CD7 PE (Mouse anti Human CD2 FITC - CD7 PE) Mouse
Mouse anti Human CD2 FITC - CD7 PE (Mouse anti Human CD2 FITC - CD7 PE) Mouse
| Application | FACS |
| Clone | |
| Conjugué | FITC, PE |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | CD2=Derived from the hybridization of mouse Sp2/0 myeloma cells with spleen cells from BALB/c mice immunized with t lymphocytes activated by mixed lymphocyte culture. CD7=Derived from the hybridization of mouse P3-X63-Ag8.653 myeloma cells with spleen cells of BALB/c mice immunized with T-acute lymphoblastic leukemia (T-ALL) cells. |
| Isotype | |
| Localisation | |
| Pathologie | |
| Predicted reactivity | |
| Purification | Protein A/G Chromatography |
| Réactivité | Human |
| Spécificité | |
| Taille | |
| Tissus controles |
Identification of human T cells and subset of NK cells associated with the receptor for sheep erythocytes rosettes expressing the 45-50,000 M.W. surface antigen. Identification of human T lymphocytes in multiple stages of T cell development, including a major subset of mature peripheral T cell. CD7 antigen is often increased on T leukemic cells. The CD7 molecule is a 40,000 M.W. surface antigen that is expressed on T-Lymphoid and myeloid precursors in fetal liver and bone marrow.